Towards Healthcare
Bone Anchored Hearing Aids (BAHA) Implants Market Size, Trends and Growth

Bone Anchored Hearing Aids (BAHA) Implants Market to Hit $511.61 Mn by 2034

In 2023, children led the global bone-anchored hearing aids (BAHA) implants market due to higher rates of hearing loss compared to adults. While children under 5 often need BAHA implants, the adult market, especially among the elderly, is set for growth. BAHA is widely used for sensorineural hearing loss.

Bone Anchored Hearing Aids (BAHA) Implants Market Companies and Segments Growth

The bone anchored hearing aids (BAHA) implants market size was estimated at US$ 215 million in 2023 and is projected to grow to US$ 511.61 million by 2034, rising at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2034. The rising incidences of hearing aid problems and the latest innovations in the medical device sector drive the market.

Bone Anchored Hearing Aids (BAHA) Implants Market Revenue 2023 to 2034

Unlock Infinite Advantages: Subscribe to Annual Membership

Bone Anchored Hearing Aids (BAHA) Implants Market Overview

Bone-anchored hearing aids (BAHA) are surgically implantable devices for people having outer or middle ear problems but at least one functioning inner ear (cochlea). BAHA sends sound waves through the bones of the skull directly into the cochlea. It consists of three parts: titanium implant, external connector, and sound processor. They are most widely used in patients with chronic otitis media, mastoiditis, and single-sided deafness. BAHA is usually suggested for children with underdeveloped ear canal or outside parts of the ear. It offers several advantages, such as better comfort, optimal sound quality, and better prediction of results.

The rising incidences of hearing aid problems, such as conductive or mixed hearing loss and single-sided deafness, potentiate the use of BAHA. According to the WHO, approximately 2.5 billion people globally are estimated to require some degree of hearing loss by 2050. The growing research and development activities and the latest innovations in the medical device sector promote the market.

The sales revenue of Cochlear Limited for the half year ended December 2023 increased by 25% to $1,113 million, with strong growth in cochlear implants and sound processor upgrades. The statutory net profit of the company increased 35% to $191 million.

  • In April 2024, A 7-year-old child with congenital ear defects and profound hearing loss had successful piezoelectric Bone Conduction Hearing Implants (BCI) at the Department of Ear, Nose, and Throat (ENT) at Command Hospital in Pune. It was the first time such cutting-edge hearing implants have been purchased and used in a government hospital in India.
  • In November 2023, the University Clinic for Otorhinolaryngology and Head and Neck Surgery was certified by ClarCert for its Cochlear Implant Center. The certification recognizes its expertise and confirms compliance with the highest structural and process quality standards following the guidelines.

Latest Innovations: Opportunity for the Bone Anchored Hearing Aids (BAHA) Implants Market

Novel innovations in the BAHA system can improve patient adherence and enhance user experience. The growing research and development activities globally are evolving with the changing needs of patients and designing more effective hearing aids at lower prices. The most general trend in hearing devices is to make them aesthetically appealing or to make them as invisible as possible. The transcutaneous hearing aids have lesser visibility than the percutaneous ones. Improvements in the screw and abutment design and the introduction of less invasive surgical techniques can reduce or eliminate the complications associated with skin penetration. Hence, the demand for minimally invasive surgical techniques promotes innovations.

High-Cost Hampers the Bone Anchored Hearing Aids (BAHA) Implants Market

The major disadvantage of the market is the high cost of the device. The average cost of a BAHA ranges from $10,000 to $17,000. The device also needs an external sound processor, which costs around $5,000 to $8,000. This restricts many patients from using BAHA, especially in low- and middle-income countries.

Regional Insights

Rising Incidences of Hearing Loss Dominated North America

North America dominated the bone anchored hearing aids (BAHA) implants market in 2023. The rising incidences of hearing impairment, technological advancements, the presence of key players, and the advanced research & development facilities. Hearing loss is rising in the US and is expected to double by the year 2060. According to the National Institute on Deafness and Other Communication Disorders, approximately 615,000 individuals have Meniere’s disease, and around 45,000 new cases are diagnosed annually in the US. It is estimated that around 7% of the US adult population has unilateral hearing loss. According to a 2022 report by the Hearing Review, approximately 60,000 to 65,000 new cases of sudden sensorineural hearing loss (SSHL) are documented in the US annually. Cochlear Limited was the first company to market BAHA in the US.

Favorable Government Policies Drives Asia-Pacific

Asia-Pacific is expected to grow at the fastest rate in the bone anchored hearing aids (BAHA) implants market during the forecast period. The rising incidences of hearing loss, growing research and development, increasing investments & collaborations, and favorable government policies drive the market. There are approximately 27 million people affected by hearing loss in China. The Chinese local governments are incorporating cochlear implants into their public health insurance schemes to reduce the cost of healthcare for residents. In August 2024, the southern island province of Hainan became the latest region to extend coverage to cochlear implant surgery. Under the ADIP scheme by the Indian Government, free cochlear implants, post-operative therapy, and rehabilitation for children with hearing impairment. In 2022-23, 1,151 cochlear implant surgeries were performed in India under the scheme. In July 2024, the Australian Government funded 6.5 million Australian dollars ($4.4 million) for the Japanese hearing implant program for children.

Segmental Insights

By type, the children type segment led the global bone anchored hearing aids (BAHA) implants market in 2023. The incidences of conductive and mixed hearing loss and single-sided deafness are higher in children compared to the adult population. It is estimated that more than 34 million children globally suffer from deafness or hearing loss. Children under 5 years or less are more likely to require BAHA implants.

The adult type segment is predicted to witness notable growth in the market over the forecast period. The rising incidences of hearing loss cases in adults, especially in the geriatric population, potentiate the segment growth.

By application, the perceptual hearing loss segment accounted for a considerable share of the bone anchored hearing aids (BAHA) implants market in 2023. Perceptual hearing loss or sensorineural hearing loss is a condition in which the inner ear is damaged. BAHA implants are predominantly used in sensorineural hearing loss. BAHA implants directly send sound waves to the inner ear, where the bones in the skull vibrate to aid hearing.

The behavioral hearing maintenance segment will gain a significant share of the market over the studied period. The behavioral hearing test involves observing how a child responds to sounds of varying intensities. BAHA implants help children to adapt to changing sound intensities.

Recent Developments in the Bone Anchored Hearing Aids (BAHA) Implants Market

  • In April 2024, Cochlear Limited gained the US FDA approval to lower the age requirement for their Cochlea Osia System from 12 to 5 years. This will extend the availability of the system to more children with conductive or mixed hearing loss or single-sided deafness.
  • In July 2024, Oticon Medical announced the US FDA approval of its first active transcutaneous bone conduction hearing system, the Sentio System, in both Europe and the US. The system offers an alternative to the existing percutaneous systems while maintaining skin integrity.

Bone Anchored Hearing Aids (BAHA) Implants Market Companies

Top Companies in the Bone Anchored Hearing Aids (BAHA) Implants Market

  • Amplifon SpA
  • Best Hearing Solutions
  • Cochlear Implants
  • Ear Associates
  • Healthy Hearing
  • MED-EL
  • Nurotron Biotechnology
  • Oticon Medical
  • Sonitus Medical
  • Sonova International
  • Starkey Laboratories Pvt. Ltd.

Segments Covered in the Report

By Type

  • Children Type
  • Adult Type

By Application

  • Perceptual Hearing Loss
  • Behavioral Hearing Maintenance
  • Others

By Region

  • North America
    • US
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
  • Insight Code: 5294
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: October 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

Meet the Team

Shivani Zoting is a healthcare market research expert with 2+ years of experience, specializing in analyzing trends, identifying growth opportunities, and providing actionable insights for businesses across healthcare sectors.

Learn more about Shivani Zoting

Aditi Shivarkar, with 14+ years of healthcare market research experience, ensures the accuracy, clarity, and relevance of reports. Her expertise helps businesses make informed decisions and stay competitive in healthcare sectors.

Learn more about Aditi Shivarkar

Related Reports

FAQ's

A bone-anchored hearing aid is a device that includes both a bone-conduction hearing aid and an implant in the skull. The hearing aid is connected to the implant.

The risks associated with BAHA implants include inflammation, infection, implant failure, and sustained head trauma.

National Institute of Health, National Institute on Deafness and Other Communication Disorders, World Health Organization.